Novak Djokovic: Tennis star to be deported after losing Australia visa appeal

Tennis star Novak Djokovic has lost his last-ditch court bid to stay in Australia and is set to be deported.

The Federal Court upheld a government decision to cancel the unvaccinated Serbian player's visa.

The government argued the 34-year-old posed a threat to public health.

Djokovic is now unable to defend his Australian Open title in Melbourne. He was due to play his first match on Monday.

During Sunday's court hearing before a three-judge panel, Djokovic's defence unsuccessfully argued that the grounds given by the government were "invalid and illogical".

Djokovic has been staying at an immigration detention hotel in Melbourne, the same place he was taken after his visa was first revoked following his arrival on 6 January.

Will we have to alter vaccines whenever a COVID-19 variant occurs?

 

Drugmakers BioNTech and Pfizer say a three-shot course of their coronavirus vaccine is effective against the newly discovered Omicron variant. BioNTech has also annouced they could have a new Omicron-specific vaccine by March 2022.

Many parents concerned over kids' vaccinations

 

Closed schools, social distancing, remote learning. Children’s lives have been turned upside down during the pandemic. More than 100 countries around the world have started to inoculate children against the coronavirus. Some parents are on the fence about the jab. But for many families vaccination is the silver lining after months of pandemic.

Covid vaccine complications dwarfed by virus risks

 

A major review of vaccines suggests the AstraZeneca jab does raise the risk of blood clots and another serious condition that can cause bleeding.

Delta variant and "vaccine apartheid" to blame for COVID-19 surge?

 

A quarter of the global population has received at least one dose of a COVID-19 vaccine. Low income countries are far behind. Just one in a hundred have at least one jab there. 24% worldwide and only 1% low income countries are vaccinated.

Could the coronavirus bring us closer to an HIV vaccine?

 HIV leads to hundreds of thousands of deaths a year. And there's no vaccine, despite decades of research.

That very research has seen several COVID vaccines developed at lightning speed.

COVID-19 vaccines for animals: Will we need to vaccinate our cats and dogs?

We're still learning about COVID-19. We know it came from an animal. But does that mean they also need the jab?
 

mRNA vaccine producer BioNTech announces expansion plans

 Vaccine makers are ramping up production. Yet, not enough of the product is made to keep everyone safe from COVID. The US and the EU are thinking about waiving patent protection to allow others to produce generic versions of proven vaccines.

Canada authorizes coronavirus vaccine for children ages 12 to 15

Vaccinations save children's lives. They protect them against diseases like measles and polio. But so far, not against COVID-19.

 

India's daily COVID cases top 400,000 amid severe vaccine shortage | DW News

India has reported a staggering 400,000 new coronavirus infections in 24-hours – adding to a week-long streak of world record breaking numbers. To battle the devastating second wave, Saturday should have marked the start of a vaccine rollout for hundreds of millions of over-18s in India

 

Astrazeneca vaccine: safe or not safe? | Inside Story

 

The European Medicines Agency says the link between AstraZeneca vaccine and blood clots is very rare.

Many countries have been relying on the AstraZeneca vaccine to get them out of the coronavirus pandemic crisis.

But there have been problems – from supply to side-effects.

US trial of Oxford-AstraZeneca vaccine confirms safety and effectiveness - BBC News

 

Results from the long-awaited US trial of the Oxford-AstraZeneca Covid vaccine have confirmed that the shot is both safe and highly effective.

Biden Says Trump Didn't Adequately Prepare for Vaccine Efforts

 'My predecessor...did not do his job in getting ready for the massive challenge of vaccinating hundreds of millions of Americans' — Pres. Biden gave blunt remarks on Trump's failure to prepare the country for the coronavirus vaccine.

UK insists AstraZeneca vaccine is effective against South African variant of Covid

 There's been a concerted effort by the UK government and its scientific advisers to reassure people about the efficacy of its vaccination programme.

How Russia and China are winning the vaccine diplomacy race

 Russia and China have been challenging the West for years. Their military build-ups, infrastructure projects and targeted economic support have bolstered their geopolitical clout. Critics say they're threatening the international order.

Covid update: Coronavirus news from around the world

 

Following criticism in Germany of the pace of the coronavirus vaccination roll-out, a health ministry official has revealed that Berlin has struck preliminary deals for an extra 50-million vaccine doses in the summer - outside what's been negotiated by the EU.

BioNTech CEO Ugur Sahin: "Our vaccine will likely work for mutated coronavirus variants" | DW News

 

“Even though this new variant has multiple mutations, only one percent of this protein is changed. And that means 99 percent are still the same,” Biontech CEO Ugur Sahin told DW. He said his company needed two weeks to determine whether the vaccine can inactivate it.

US crosses horrific milestone mid-interview. See Azar's response

 More than 300,000 people in the US have now died from Covid-19. CNN's Jake Tapper asks HHS secretary Alex Azar why the US is struggling to deal with this pandemic.

How dangerous can mutated coronavirus strains be?

 Mutated coronavirus strains were reported among farmed minks. More than 15 million will be culled. Medical experts fear that could jeopardize the effectiveness of future COVID-19 vaccines. Has the virus already found a way to beat the vaccines?

Are vaccine developers stretching medical ethics?

 With news that a Vaccine might be around the corner vaccine developers BioNTech and Pfizer have sparked a surge of optimism. But the unsung heroes of this tale are the thousands of unpaid volunteers taking part in clinical trials, many in Latin America.